NCT01495676 2025-10-10
GETUGV04
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Terminated
Clinical Trials
6 trialsNCT05671900 2024-03-08
Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer
Clinical Hospital Centre Zagreb
Phase NA Active not recruiting
NCT05626101 2024-02-13
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
Al-Azhar University
Phase NA Unknown
NCT02944357 2017-11-17
Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery
Mayo Clinic
Phase NA Withdrawn
NCT02716961 2016-03-24
Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase NA Unknown
NCT01801644 2013-03-01
Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer
Barmherzige Brüder Vienna
Phase NA Completed